Progyny, Inc. Announces Second Quarter 2020 Results

Go back to Progyny, Inc. Announces Second Quarter 2020 Results

Progyny (PGNY) Tops Q2 EPS by 1c, Revenues Miss; Offers FY20 Revenue Guidance Below Consensus

August 5, 2020 5:51 PM EDT

Progyny (NASDAQ: PGNY) reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $64.6 million versus the consensus estimate of $48.26 million.

Earlier in the year, while access to care was significantly disrupted by the pandemic, our members remained eager to resume treatment once they were able to do so safely. As clinics began to reopen... More